HER2-Positive Breast Cancer Treatment and Resistance.

导出 LinkOut

翻译打印收藏纠错

作者： Jamunarani,Veeraraghavan ^[1] ; Carmine,De Angelis ^[2] ; Carolina,Gutierrez ^[2] ; Fu-Tien,Liao ^[2] ; Caroline,Sabotta ^[3] ; Mothaffar F,Rimawi ^[1] ; C Kent,Osborne ^[4] ; Rachel,Schiff ^[5]

作者单位： Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.;Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.;Department of Medicine, Baylor College of Medicine, Houston, TX, USA. ^[1] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.;Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. ^[2] Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. ^[3] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.;Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.;Department of Medicine, Baylor College of Medicine, Houston, TX, USA.;Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. ^[4] Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu.;Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu.;Department of Medicine, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu.;Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. rschiff@bcm.edu. ^[5]

关键词 Estrogen receptor Genetic aberrations Growth factor receptors HER2 HER2-targeted therapy Receptor cross talk Treatment resistance